Search results

Period 1: Sep. 1 - Oct. 31 Period 2: Nov. 3 - Jan. 16 Period 1: Jan. 19 - Mar. 20 Period 2: Mar. 23 - Jun. 5 Cell- and Microbiology BIOA10 15 cr Genetics and Evolution BIOA11 15 cr Human and Animal Physiology BIOB13 15 cr Ecology BIOC13 15 cr Ecology BIOC13 15 cr Botany and Zoology BIOB10 15 cr (autumn, 2026) Ecology BIOC12 7.5 cr, a Human and Animal Physiology BIOC11 15 cr Human and Animal Physio

https://www.biologyeducation.lu.se/sites/biologyeducation.lu.se/files/2025-06/Courses_Department_of_Biology_25-26.pdf - 2025-10-14

Autumnt 2025, period 1, 1/9 -31/10 Autumn 2025, period 2, 3/11 - 16/1 Spring 2026, period 1, 19/1 - 20/3 Spring 2026, period 2, 23/3 - 5/6 Bioinformatics BINP17, 7,5 cr, a Animal Ecology BIOR91 Applied Ecotoxicology BIOR52 Antibiotics BIOR56, 7.5 cr, a Bryophyte BIOR97 5cr (online) Ecotoxicology BIOR41 Aquatic Ecology BIOR82 Applied Bioinformatics BIOR93, 7.5 cr, b Evol Biol, Patterns/ Processes B

https://www.biologyeducation.lu.se/sites/biologyeducation.lu.se/files/2025-09/CoursePlanningBiology25-26.pdf - 2025-10-14

Postal adress: Box 117, 221 00 Lund, Sweden Visiting adress: Sandgatan 13A, Gamla Kirurgen, 223 50 Lund, Sweden Phone: +46 46-222 00 00 Fax: 046-222 44 11 E-mail: info@sam.lu.se Website: www.sam.lu.se/en A world-class university that understands, explains and improves our world and the human condition Strategy for the Faculty of Social Sciences, 2021–2026 The faculty is to attract and retain commi

https://www.sam.lu.se/en/internal/sites/sam.lu.se.en.internal/files/2021-02/strategy_social_sciences_2021-26.pdf - 2025-10-14

Master’s programme in Entrepreneurship and Innovation – Statement of purpose, year 2024/2025 1/32023-10-13 Master’s programme in Entrepreneurship and Innovation STATEMENT OF PURPOSE | YEAR 2025/2026 The statement of purpose is one of the most important, and challenging, elements of your application. It is your opportunity to stand out from the hundreds of other ap- plicants to our programmes. Your

https://www.lusem.lu.se/sites/lusem.lu.se/files/2024-10/Statement%20of%20purpose%202025-26%20Entr-innov%20LUSEM.pdf - 2025-10-14

Master’s programme in Accounting and Finance – Statement of purpose, year 2024/2025 1/42023-10-13 Master’s programme in Accounting and Finance STATEMENT OF PURPOSE | YEAR 2025/2026 The statement of purpose is an important, required element of your application. It is your opportunity to draw our attention to your previous academic experience and to stand out from hundreds of other applicants to the

https://www.lusem.lu.se/sites/lusem.lu.se/files/2024-10/Statement%20of%20purpose%202025-26%20accounting-finance-LUSEM.pdf - 2025-10-14

Magisterprogram i finans, kurslitteratur – HT2025/VT2026 MSc in Finance, literature - autumn term 2025/spring term 2026 NEKN81 Foundations of Finance Danthine, Jean-Pierre and John B. Donaldson, (2024): Intermediate Financial Theory, fourth edition, Elsevier. Supplementary material. NEKN82 Empirical Finance Lecture notes that are available in the learning management system. Supplementary material.

https://www.lusem.lu.se/sites/lusem.lu.se/files/2025-06/Litteratur-FIN-ht25-vt26.pdf - 2025-10-14

academic positions. The applicant had given specifications about having applied for two such positions, but did not report the final outcome of those applications. More information an the ranking is needed before finally excluding this applicant from support. §8. Update on the planned process for steering group to prepare the 2022 infrastructure budget allocations Angela Cenci Nilsson gave an upda

https://www.multipark.lu.se/sites/multipark.lu.se/files/2021-10/2021-09-26%20MultiPark%20board%20minutes.pdf - 2025-10-14

Application Surname, name Date of birth / personal identification number (YY-MM-DD) Home address Sex Female Male Post code, city, country Telephone E-mail If applicable, former surname Relevant education Degree/education (enclose official transcript) Credits Date University Country Application intended for Department Faculty Research subject Application is intended for the following degree Licenti

https://www.lusem.lu.se/sites/lusem.lu.se/files/2024-01/EHL-antagningsblankett-FU-eng.pdf - 2025-10-14

Background: European Union law prohibits companies from marketing drugs off-label. In the United Kingdom — as in some other European countries, but unlike the United States — industry self-regulatory bodies are tasked with supervising compliance with marketing rules. The objectives of this study were to (1) characterize off-label promotion rulings in the UK compared to the whistleblower-initiated

Mot smartare cellgiftsbehandling: Att förebygga behandlingsresistens vid äggstockscancer Äggstockscancer är den dödligaste gynekologiska cancertypen och kräver alltför många liv eftersom tumörer ofta blir resistenta mot behandling – särskilt mot cisplatin, vårt främsta försvar. För att rädda fler liv måste vi förstå hur denna resistens utvecklas och hur vi kan överlista den. I mitt examensarbete Ovarian cancer is the deadliest gynaecologic malignancy, with most patients diagnosed at an advanced stage and facing poor long-term survival. Resistance to cisplatin-based chemotherapy is a major clinical obstacle, yet its proteomic drivers remain poorly defined. In this study, I applied data-independent acquisition mass spectrometry with DIA-NN data processing to analyse one parental and two cis

Background Anti-interleukin (IL)-4Rα monoclonal antibodies (mAb) improve lung function and decreasethe number of exacerbations in patients with COPD type (T) 2 inflammation. However, the involvement ofearly innate immune responses underlying these treatment effects is not well known. We sought tounderstand the effect and mechanisms of IL-4Rα mAb treatment on bronchial epithelial cells (BECs) fromCBackgroundAnti-IL-4Rα monoclonal antibodies (mAb) improve lung function and decrease the number of exacerbations in patients with COPD type (T) 2 inflammation. However, the involvement of early innate immune responses underlying these treatment effects is not well known. We sought to understand the effect and mechanisms of IL-4Rα mAb treatment on bronchial epithelial cells from COPD patients under

Hemicelluloses account for 25-30% of total wood dry weight. Mannan-based polysaccharides are the major component of softwood hemicelluloses. They are characterized by their β-1,4-glycosidic linked backbone composed of mannose or a combination of mannose and glucose residues. The backbone can be substituted by α-1,6-linked galactose residues. β-mannanases cleave the internal β-1,4-glycosidic bonds